Cover Image
市場調查報告書

尋常性魚鱗癬:全球臨床實驗檢討

Ichthyosis Vulgaris Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 296022
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
尋常性魚鱗癬:全球臨床實驗檢討 Ichthyosis Vulgaris Global Clinical Trials Review, H2, 2017
出版日期: 2017年10月31日 內容資訊: 英文 36 Pages
簡介

本報告提供尋常性魚鱗癬治療藥的相關臨床實驗資料,彙整臨床實驗數及被實驗人數,各階段及各方面狀況,有潛力的企業,開發中的治療藥等資訊,為您概述為以下內容。

簡介

各地區的臨床實驗趨勢

  • 各國臨床實驗趨勢
    • 歐洲的主要5個國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗

G7各國的臨床實驗:各臨床實驗狀況

各方面的臨床實驗情形

現在進行中的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 尋常性魚鱗癬治療藥參與臨床實驗的主要企業

潛力治療藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • ORFAGEN
    • Laboratoires Pierre Fabre SA
    • GlaxoSmithKline plc
    • Galderma S.A.
  • 主要大學/實驗室/醫院臨床實驗概要
    • FDA Office of Orphan Products Development
    • National Human Genome Research Institute
    • The National Institute of Allergy and Infectious Diseases
    • Uppsala University
    • Northwestern University
    • Hopital Necker-Enfants Malades
    • National Cancer Institute
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4641CTIDB

GlobalData's clinical trial report, "Ichthyosis Vulgaris Global Clinical Trials Review, H2, 2017" provides an overview of Ichthyosis Vulgaris clinical trials scenario. This report provides top line data relating to the clinical trials on Ichthyosis Vulgaris. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials 17
  • Clinical Trials by Phase 18
  • Clinical Trials by Trial Status 19
  • Clinical Trials by End Point Status 20
  • Subjects Recruited Over a Period of Time 21
  • Clinical Trials by Sponsor Type 22
  • Prominent Sponsors 23
  • Top Companies Participating in Ichthyosis Vulgaris Therapeutics Clinical Trials 24
  • Prominent Drugs 25
  • Clinical Trial Profile Snapshots 26

Appendix 34

  • Abbreviations 34
  • Definitions 34
  • Research Methodology 35
  • Secondary Research 35
  • About GlobalData 36
  • Contact Us 36
  • Source 36

List of Tables

List of Tables

  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 14
  • Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 17
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2017* 18
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
  • Ichthyosis Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 22
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25

List of Figures

List of Figures

  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
  • Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 14
  • Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 17
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2017* 18
  • Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
  • Ichthyosis Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 22
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
  • Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25
  • GlobalData Methodology 35
Back to Top